concept

SENESCENT CELLS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SENESCENT CELLS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

83Connections

0Hypotheses

1Analyses

38Outgoing

45Incoming

0Experiments

1Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	SENESCENT CELLS
Related Diseases	neurodegenerative disorders
Related Pathways	brain aging

Pathway Diagram

graph TD
    SENESCENT_CELLS["SENESCENT CELLS"]
    SENESCENT_CELLS -->|"upregulates"| Pro_survival_Networks["Pro-survival Networks"]
    SENESCENT_CELLS -->|"develops"| SASP["SASP"]
    SENESCENT_CELLS -->|"inhibits"| Apoptosis["Apoptosis"]
    SENESCENT_CELLS -->|"contributes to"| Age_related_Chronic_Diseases["Age-related Chronic Diseases"]
    SENESCENT_CELLS -->|"inhibits"| Hematopoietic_Stem_Cells["Hematopoietic Stem Cells"]
    SENESCENT_CELLS -->|"target for"| chronic_kidney_disease["chronic kidney disease"]
    SENESCENT_CELLS -->|"promotes"| skin_aging["skin aging"]
    SENESCENT_CELLS -->|"contributes to"| Aging["Aging"]
    Abt263["Abt263"] -->|"targets"| SENESCENT_CELLS
    Senolytics["Senolytics"] -->|"targets"| SENESCENT_CELLS
    Senolytic_Drugs["Senolytic Drugs"] -->|"targets"| SENESCENT_CELLS
    ABT263["ABT263"] -->|"targets"| SENESCENT_CELLS
    Hesc_Exos["Hesc-Exos"] -->|"modulates"| SENESCENT_CELLS
    senescent_cell_anti_apoptotic_["senescent cell anti-apoptotic pathways"] -.prevents.-> SENESCENT_CELLS
    senolytics["senolytics"] -->|"treats"| SENESCENT_CELLS
    Total_Body_Irradiation["Total-Body Irradiation"] -->|"causes"| SENESCENT_CELLS

Outgoing (38)

Target	Relation	Type	Str
SASP	develops	phenotype	0.95
Healthspan	associated_with	phenotype	0.95
Pro-survival Networks	upregulates	pathway	0.95
Aging	associated_with	disease	0.95
Ventricular Enlargement	contributes_to	phenotype	0.90
NEURODEGENERATION	associated_with	process	0.90
Neurodegeneration	promotes	process	0.90
Blood-Brain Barrier	associated_with	brain_region	0.90
Apoptosis	inhibits	process	0.90
Age-related Chronic Diseases	contributes_to	disease	0.90
Inflammatory Cytokines	associated_with	compound	0.90
Neuroinflammatory Responses	promotes	process	0.90
Hematopoietic Stem Cells	inhibits	cell_type	0.90
chronic kidney disease	therapeutic_target	disease	0.90
skin aging	promotes	phenotype	0.90
Hematopoietic stem cells	impairs	cell_type	0.90
Wound Healing	involved_in	process	0.90
Tumor Suppression	involved_in	process	0.90
Neurofibrillary Tangles	contributes_to	phenotype	0.90
Age-Related Diseases	causes	disease	0.90
Age-Related Diseases	contributes_to	disease	0.85
INFLAMMATORY CYTOKINES	associated_with	protein	0.85
aging	promotes	process	0.85
Hematopoietic Stem Cells	associated_with	cell_type	0.85
Aging Pathology	causes	disease	0.85
Neural Microenvironment	modulates	mechanism	0.85
Age-Related Chronic Diseases	contributes_to	disease	0.80
age-related pathologies	causes	phenotype	0.80
brain aging	causes	biological_process	0.80
Quality Of Life	associated_with	phenotype	0.80
Senescence-Associated Secretory Phenotype	associated_with	biological_process	0.80
neurodegenerative disorders	implicated_in	disease	0.80
neurodegeneration	contributes_to	disease	0.80
therapeutic target	therapeutic_target	process	0.75
fibrosis	activates	process	0.70
fibrosis	causes	disease	0.70
Alzheimer's disease	causes	disease	0.70
amyloid-beta deposition	contributes_to	process	0.60

Incoming (45)

Source	Relation	Type	Str
Senolytic Drugs	targets	drug	0.95
Abt263	targets	drug	0.95
Senolytics	targets	drug	0.95
cell cycle arrest	associated_with	phenotype	0.95
Senolytics	targets	drug	0.95
CDKN1A	expressed_in	gene	0.95
Senolytic Therapy	targets	drug	0.95
Hesc-Exos	modulates	compound	0.95
ABT263	targets	drug	0.95
Total-Body Irradiation	associated_with	process	0.91
Dasatinib	targets	drug	0.90
SERPINE2	expressed_in	gene	0.90
senescent cell anti-apoptotic pathways	prevents	pathway	0.90
senolytics	treats	drug	0.90
ABT263	clears	compound	0.90
MICROGLIA	involved_in	cell_type	0.90
Quercetin	targets	compound	0.90
Abt263	associated_with	drug	0.90
EFNB1	expressed_in	gene	0.90
EFNB3	expressed_in	gene	0.90
Luteolin	targets	compound	0.85
Transgenic Suicide Gene	targets	mechanism	0.85
EFNB1	involved_in	gene	0.85
PIK3CD	involved_in	gene	0.85
BCL2L1	involved_in	gene	0.85
TP53I2	involved_in	gene	0.85
Microglia	involved_in	cell_type	0.85
dasatinib	associated_with	drug	0.85
Total-Body Irradiation	causes	process	0.85
Venetoclax	targets	drug	0.85
Navitoclax	targets	drug	0.85
Fisetin	targets	compound	0.85
DASATINIB	targets	drug	0.80
NAVITOCLAX	targets	drug	0.80
DASATINIB	targets	drug	0.80
SENOLYTICS	eliminates	drug	0.80
quercetin	associated_with	compound	0.80
Senotherapies	targets	drug	0.80
P21	expressed_in	gene	0.80
Dasatinib	inhibits	drug	0.70
Fisetin	inhibits	drug	0.70
Navitoclax	inhibits	drug	0.70
Quercetin	inhibits	drug	0.70
senolytic drugs	treats	drug	0.70
ABT-263	inhibits	drug	0.70

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.910

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (1)

Multi-agent debates referencing this entity

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP

closed · Rounds: 4 · Score: 0.89 · 2026-04-06

Related Research

Hypotheses and analyses mentioning SENESCENT CELLS in their description or question text

No additional research found